AbSci
Curated by SignalDeveloper of AI based technology for the production of recombinant protein for therapeutic applications
Overview
Developer of AI based technology for the production of recombinant protein for therapeutic applications. The company's integrated drug creation platform enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
Key facts
- Founded
- 2011
- Headquarters
- Vancouver, United States
- Stage
- Sign up to view
- Industry
- High Technology
Business model
- 4 products and services
- Sign up to view
Contact
- Primary office
- Sign up to view
- Sign up to view
- Phone
- Sign up to view
Open roles
20 rolesDirector, Program Management
New York, NY · On-site · Volunteer
Director, Program Management
Vancouver, WA · On-site · Volunteer
Staff/Principal AI Scientist - Virtual Tissue
United States · On-site · Volunteer